Vorinostat Terminated Phase 2 Trials for Recurrent Uveal Melanoma / Stage IV Uveal Melanoma AJCC v7 / Ocular Melanoma With Extraocular Extension / Stage IV Uveal Melanoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01587352Vorinostat in Treating Patients With Metastatic Melanoma of the Eye